Bio Path reported $0 in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 47M 9M Jul/2026
Baxter International USD 8.67B 1.15B Mar/2026
Bio Path USD 1000K 0 Sep/2025
Cipla INR 988.89B 231.9B Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 573.66M 46.63M Jul/2026
CSL USD 55.89B 20.42B Dec/2025
Karyopharm Therapeutics USD 1.12B 989M Jul/2026